OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate. (2024)
Attributed to:
OpenSAFELY, ISARIC, PHOSP: tracking consequences of COVID-19 infection across UK primary and secondary care.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bcp.16062
PubMed Identifier: 38589944
Publication URI: http://europepmc.org/abstract/MED/38589944
Type: Journal Article/Review
Parent Publication: British journal of clinical pharmacology
ISSN: 0306-5251